The Asia Pacific Protein Therapeutics Market would witness market growth of 7.7% CAGR during the forecast period (2022-2028).
Protein treatments represent a promising market due to their numerous benefits over small-molecule medications. They are frequently well absorbed and less prone to disrupt regular biological functions. Protein therapies are frequently utilized to treat a variety of disorders including diabetes, and multiple sclerosis due to their high specificity and low immunogenicity. Protein is a crucial part of every living creature. One or more polypeptide chains consisting of amino acids make up each protein molecule.
Peptide bonds are used to connect various amino acid sequences to create protein chains. Each amino acid in a protein is in a specific order. Protein structures are necessary for all of their functions. Proteins carry out a variety of biological tasks within animals, including enzyme defense, catalysis, transport, support, mobility, and control, even though DNA or RNA encodes the information required for life.
The main method of obtaining a particular protein in the past was to isolate it from any natural source, which is typically ineffective and time-consuming. It is now also feasible to replicate the DNA encoding a particular protein into an expression vector to express the protein in expression systems including bacteria, insect cells, yeast, and mammalian cells owing to recent developments in recombinant molecular biology techniques. Recombinant proteins, to put it simply, are the translated by-products of exogenous DNA in live cells.
One of the major reasons that are increasing the adoption of protein therapeutics in the region is the growing geriatric population within regional countries. A wide range of chronic illnesses with a decreased quality of life for the elderly are mostly brought on by aging. According to the National Library of Medicine, Chinese residents made up 18% of the global population in 2019, with 164.5 million of them being 65 or older and 26 million being 80 or older. China has an aging population, and as it does, the strain on the nation's family and public healthcare systems will only become worse.
The China market dominated the Asia Pacific Protein Therapeutics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $39,387.6 million by 2028. The Japan market is estimated to witness a CAGR of 7% during (2022 - 2028). Additionally, The India market is anticipated to grow a CAGR of 8.3% during (2022 - 2028).
Based on Product, the market is segmented into Monoclonal Antibodies, Human Growth Hormone, Fusion Protein, Insulin, Erythropoietin, Interferon and Follicle Stimulating Hormone. Based on Application, the market is segmented into Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Protein Therapeutics Market is Projected to reach USD 490.2 Billion by 2028, at a CAGR of 6.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Baxter International, Inc., Amgen, Inc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Merck & Co., Inc., Johnson & Johnson (Janssen Global Services, LLC), Pfizer, Inc., Novo Nordisk A/S and Sanofi S.A.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Monoclonal Antibodies
- Human Growth Hormone
- Fusion Protein
- Insulin
- Erythropoietin
- Interferon
- Follicle Stimulating Hormone
By Application
- Metabolic Disorders
- Immunologic Disorders
- Hematological Disorders
- Cancer
- Hormonal Disorders
- Genetic Disorders
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Baxter International, Inc.
- Amgen, Inc.
- F. Hoffmann-La Roche Ltd.
- Eli Lilly And Company
- Merck & Co., Inc.
- Johnson & Johnson (Janssen Global Services, LLC)
- Pfizer, Inc.
- Novo Nordisk A/S
- Sanofi S.A.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Protein Therapeutics Market, by Product
1.4.2 Asia Pacific Protein Therapeutics Market, by Application
1.4.3 Asia Pacific Protein Therapeutics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Product Launches and Product Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisition and Mergers: 2018, Mar – 2022, Jun) Leading Players
Chapter 4. Asia Pacific Protein Therapeutics Market by Product
4.1 Asia Pacific Monoclonal Antibodies Market by Country
4.2 Asia Pacific Human Growth Hormone Market by Country
4.3 Asia Pacific Fusion Protein Market by Country
4.4 Asia Pacific Insulin Market by Country
4.5 Asia Pacific Erythropoietin Market by Country
4.6 Asia Pacific Interferon Market by Country
4.7 Asia Pacific Follicle Stimulating Hormone Market by Country
Chapter 5. Asia Pacific Protein Therapeutics Market by Application
5.1 Asia Pacific Metabolic Disorders Market by Country
5.2 Asia Pacific Immunologic Disorders Market by Country
5.3 Asia Pacific Hematological Disorders Market by Country
5.4 Asia Pacific Cancer Market by Country
5.5 Asia Pacific Hormonal Disorders Market by Country
5.6 Asia Pacific Genetic Disorders Market by Country
5.7 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Protein Therapeutics Market by Country
6.1 China Protein Therapeutics Market
6.1.1 China Protein Therapeutics Market by Product
6.1.2 China Protein Therapeutics Market by Application
6.2 Japan Protein Therapeutics Market
6.2.1 Japan Protein Therapeutics Market by Product
6.2.2 Japan Protein Therapeutics Market by Application
6.3 India Protein Therapeutics Market
6.3.1 India Protein Therapeutics Market by Product
6.3.2 India Protein Therapeutics Market by Application
6.4 South Korea Protein Therapeutics Market
6.4.1 South Korea Protein Therapeutics Market by Product
6.4.2 South Korea Protein Therapeutics Market by Application
6.5 Singapore Protein Therapeutics Market
6.5.1 Singapore Protein Therapeutics Market by Product
6.5.2 Singapore Protein Therapeutics Market by Application
6.6 Malaysia Protein Therapeutics Market
6.6.1 Malaysia Protein Therapeutics Market by Product
6.6.2 Malaysia Protein Therapeutics Market by Application
6.7 Rest of Asia Pacific Protein Therapeutics Market
6.7.1 Rest of Asia Pacific Protein Therapeutics Market by Product
6.7.2 Rest of Asia Pacific Protein Therapeutics Market by Application
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Baxter International, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Approvals and Trials:
7.2.5.2 Acquisition and Mergers:
7.3 Amgen, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations, and Agreements:
7.3.5.2 Acquisition and Mergers:
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Eli Lilly And Company
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.5.2 Acquisition and Mergers:
7.6 Merck & Co., Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.6.5.2 Acquisition and Mergers:
7.7 Johnson & Johnson (Janssen Global Services, LLC)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental &Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 Recent strategies and developments:
7.7.5.1 Product Launches and Product Expansions:
7.7.5.2 Acquisition and Mergers:
7.8 Pfizer, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional & Segmental Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and Mergers:
7.9 Novo Nordisk A/S
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental & Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Partnerships, Collaborations, and Agreements:
7.10. Sanofi S.A.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
TABLE 1 Asia Pacific Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Protein Therapeutics Market
TABLE 4 Product Launches And Product Expansions– Protein Therapeutics Market
TABLE 5 Acquisition and Mergers– Protein Therapeutics Market
TABLE 6 Trial and Approvals– Protein Therapeutics Market
TABLE 7 Asia Pacific Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Monoclonal Antibodies Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Monoclonal Antibodies Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Human Growth Hormone Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Human Growth Hormone Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Fusion Protein Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Fusion Protein Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Insulin Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Insulin Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Erythropoietin Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Erythropoietin Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Interferon Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Interferon Market by Country, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Follicle Stimulating Hormone Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Follicle Stimulating Hormone Market by Country, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 25 Asia Pacific Metabolic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 26 Asia Pacific Metabolic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 27 Asia Pacific Immunologic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 28 Asia Pacific Immunologic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 29 Asia Pacific Hematological Disorders Market by Country, 2018 - 2021, USD Million
TABLE 30 Asia Pacific Hematological Disorders Market by Country, 2022 - 2028, USD Million
TABLE 31 Asia Pacific Cancer Market by Country, 2018 - 2021, USD Million
TABLE 32 Asia Pacific Cancer Market by Country, 2022 - 2028, USD Million
TABLE 33 Asia Pacific Hormonal Disorders Market by Country, 2018 - 2021, USD Million
TABLE 34 Asia Pacific Hormonal Disorders Market by Country, 2022 - 2028, USD Million
TABLE 35 Asia Pacific Genetic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 36 Asia Pacific Genetic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 37 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 38 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 39 Asia Pacific Protein Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 40 Asia Pacific Protein Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 41 China Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 42 China Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 43 China Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 44 China Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 45 China Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 46 China Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 47 Japan Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 48 Japan Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 49 Japan Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 50 Japan Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 51 Japan Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 52 Japan Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 53 India Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 54 India Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 55 India Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 56 India Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 57 India Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 58 India Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 59 South Korea Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 60 South Korea Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 61 South Korea Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 62 South Korea Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 63 South Korea Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 64 South Korea Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 65 Singapore Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 66 Singapore Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 67 Singapore Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 68 Singapore Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 69 Singapore Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 70 Singapore Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 71 Malaysia Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 72 Malaysia Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 73 Malaysia Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 74 Malaysia Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 75 Malaysia Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 76 Malaysia Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 77 Rest of Asia Pacific Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 78 Rest of Asia Pacific Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 79 Rest of Asia Pacific Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 80 Rest of Asia Pacific Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 81 Rest of Asia Pacific Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 82 Rest of Asia Pacific Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 83 Key Information – Abbott Laboratories
TABLE 84 Key Information – Baxter International, Inc.
TABLE 85 Key Information – Amgen, Inc.
TABLE 86 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 87 Key Information – Eli Lilly And Company
TABLE 88 KEY INFORMATION - MERCK & CO., INC.
TABLE 89 Key information –Johnson & Johnson
TABLE 90 Key Information – Pfizer, Inc.
TABLE 91 Key information – Novo Nordisk A/S
TABLE 92 Key Information – Sanofi S.A.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Acquisition and Mergers: 2018, Mar – 2022, Jun) Leading Players
FIG 5 Swot analysis: Abbott laboratories
FIG 6 Recent strategies and developments: Merck & Co., Inc.